CWAM
CLVS

Columbia Wanger Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Columbia Wanger Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$35M Sell
514,996
-66,664
-11% -$4.66M 0.52% 81
2017
Q3 		$47.9M Buy
+581,660
New +$46.1M 0.71% 48
2017
Q1 		– Sell
-189,958
Closed -$8.44M – 212
2016
Q4 		$8.44M Sell
189,958
-14,042
-7% -$494K 0.12% 182
2016
Q3 		$7.35M Buy
+204,000
New +$4.38M 0.1% 190

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Columbia Wanger Asset Management's CLVS Position: Q4 2017 in Review

Columbia Wanger Asset Management reduced its Clovis Oncology, Inc. (CLVS) stake by 11% in Q4 2017, selling an estimated $4.66M and leaving 514,996 shares worth $35M. The position accounts for 0.52% of the portfolio, ranked #81.

Columbia Wanger Asset Management first reported a position in CLVS in Q3 2016 and has held it in 4 quarters since. The position peaked at $47.9M in Q3 2017. 247 funds tracked by Wall St. Rank hold CLVS as of Q4 2017.

  • Columbia Wanger Asset Management held 514,996 shares of Clovis Oncology, Inc. worth $35M as of Q4 2017.
  • Columbia Wanger Asset Management sold 66,664 Clovis Oncology, Inc. shares in Q4 2017, an estimated $4.66M.
  • Clovis Oncology, Inc. made up 0.52% of Columbia Wanger Asset Management's portfolio in Q4 2017, its #81 holding.
  • Columbia Wanger Asset Management first reported a position in Clovis Oncology, Inc. in Q3 2016 and has held it in 4 quarters since.
  • Columbia Wanger Asset Management's Clovis Oncology, Inc. position peaked at $47.9M in Q3 2017.
  • 247 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2017.

Based on Columbia Wanger Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.